Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review
Simon Galmiche, Liêm Binh Luong Nguyen, Éric Tartour, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 163-177
Open Access | Times Cited: 175

Showing 1-25 of 175 citing articles:

Vaccines and therapeutics for immunocompromised patients with COVID-19
Shmuel Shoham, Carolina Batista, Yanis Ben Amor, et al.
EClinicalMedicine (2023) Vol. 59, pp. 101965-101965
Open Access | Times Cited: 84
COVID-19 vaccine effectiveness among immunocompromised populations: a targeted literature review of real-world studies
Manuela Di Fusco, Jay Lin, Shailja Vaghela, et al.
Expert Review of Vaccines (2022) Vol. 21, Iss. 4, pp. 435-451
Open Access | Times Cited: 78
Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial
Rona Smith, Rachel Jones, Ulrich Specks, et al.
Annals of the Rheumatic Diseases (2023) Vol. 82, Iss. 7, pp. 937-944
Open Access | Times Cited: 61
COVID-19 hospitalisations in immunocompromised individuals in the Omicron era: a population-based observational study using surveillance data in British Columbia, Canada
Taraneh Bahremand, Jiayun Yao, Christopher Mill, et al.
The Lancet Regional Health - Americas (2023) Vol. 20, pp. 100461-100461
Open Access | Times Cited: 41
COVID-19 and the peripheral nervous system
Benjamin Béland, Sarah Jacob, Gerald Pfeffer, et al.
Elsevier eBooks (2025), pp. 481-501
Closed Access | Times Cited: 1
Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trial
Ghady Haidar, S. Thomas, Paul Loubet, et al.
The Lancet Infectious Diseases (2025)
Closed Access | Times Cited: 1
Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
Thomas Marjot, Christiane S. Eberhardt, Tobias Boettler, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 4, pp. 1161-1197
Open Access | Times Cited: 62
Factors Associated With Severe COVID-19 Among Vaccinated Adults Treated in US Veterans Affairs Hospitals
Austin D Vo, Jennifer La, Julie T.-Y. Wu, et al.
JAMA Network Open (2022) Vol. 5, Iss. 10, pp. e2240037-e2240037
Open Access | Times Cited: 45
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19
Caroline Hirsch, Yun Soo Park, Vanessa Piechotta, et al.
Cochrane library (2022) Vol. 2022, Iss. 6
Open Access | Times Cited: 38
Analysis of mRNA COVID-19 Vaccine Uptake Among Immunocompromised Individuals in a Large US Health System
Sara Y. Tartof, Jeff Slezak, Laura Puzniak, et al.
JAMA Network Open (2023) Vol. 6, Iss. 1, pp. e2251833-e2251833
Open Access | Times Cited: 23
Relationship Between Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Development of Breakthrough Infection in Solid Organ Transplant Recipients: The CONTRAST Cohort
Cecilia Bonazzetti, Beatrice Tazza, Dino Gibertoni, et al.
Clinical Infectious Diseases (2023) Vol. 76, Iss. 10, pp. 1761-1767
Open Access | Times Cited: 21
Next-generation treatments: Immunotherapy and advanced therapies for COVID-19
Jenny Andrea Arévalo-Romero, Sandra M. Chingaté-López, Bernardo Camacho, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e26423-e26423
Open Access | Times Cited: 8
mRNA vaccine boosters and impaired immune system response in immune compromised individuals: a narrative review
Alberto Boretti
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 7
Vaccination for the Prevention of Infection among Immunocompromised Patients: A Concise Review of Recent Systematic Reviews
Kay Choong See
Vaccines (2022) Vol. 10, Iss. 5, pp. 800-800
Open Access | Times Cited: 33
The risk and consequences of breakthrough SARS-CoV-2 infection in solid organ transplant recipients relative to non-immunosuppressed controls
Amanda J. Vinson, Alfred Anzalone, Jing Sun, et al.
American Journal of Transplantation (2022) Vol. 22, Iss. 10, pp. 2418-2432
Open Access | Times Cited: 31
Effect of Systemic Lupus Erythematosus and Immunosuppressive Agents on COVID‐19 Vaccination Antibody Response
Michelle Petri, Daniel Joyce, Kristin Haag, et al.
Arthritis Care & Research (2023) Vol. 75, Iss. 9, pp. 1878-1885
Open Access | Times Cited: 19
Assessing the risk and costs of COVID-19 in immunocompromised populations in a large United States commercial insurance health plan: the EPOCH-US Study
Amita Ketkar, Vincent J. Willey, Michael Pollack, et al.
Current Medical Research and Opinion (2023) Vol. 39, Iss. 8, pp. 1103-1118
Open Access | Times Cited: 19
Real-World Safety of COVID-19 mRNA Vaccines: A Systematic Review and Meta-Analysis
Wanqian Xu, Weigang Ren, Tongxin Wu, et al.
Vaccines (2023) Vol. 11, Iss. 6, pp. 1118-1118
Open Access | Times Cited: 17
Immune responses following BNT162b2 XBB.1.5 vaccination in patients on haemodialysis in Germany
Anne Cossmann, Markus Hoffmann, Metodi V. Stankov, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 3, pp. e145-e146
Open Access | Times Cited: 5
Testing for SARS-CoV-2: lessons learned and current use cases
Elitza S. Theel, James E. Kirby, Nira R. Pollock
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 5
How Immunocompromised Hosts Were Left Behind in the Quest to Control the Covid-19 Pandemic
Michael Boeckh, Steven A. Pergam, Ajit P. Limaye, et al.
Clinical Infectious Diseases (2024)
Open Access | Times Cited: 5
Impaired Hepatitis B and COVID-19 vaccination responses show strong concordance in hemodialysis patients with end stage renal disease
Karsten Lürken, Anna Meinecke, Luis A. Manthey, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access
Riesgo similar de hospitalización y letalidad por COVID-19 en trasplantados y pacientes en lista de espera: un análisis comparativo
Abelardo Claudio Fernández Chávez, Guillermo Yovany Ordoñez León, Eva Elisa Álvarez León, et al.
Enfermedades Infecciosas y Microbiología Clínica (2025)
Closed Access
A third COVID-19 vaccine dose in kidney transplant recipients induces antibody response to vaccine and Omicron variants but shows limited Ig subclass switching
J. Lee, Jaiprasath Sachithanandham, John S. Lee, et al.
Microbiology Spectrum (2025)
Open Access
Efficacy, immunogenicity, and safety of the Novavax COVID-19 vaccine in immunocompromised patients: A targeted literature review
Manuela H Gschwend, Anthony M. Marchese, Dirk Poelaert, et al.
Vaccine (2025) Vol. 49, pp. 126777-126777
Open Access
Page 1 - Next Page

Scroll to top